Generalised Lipodystrophy clinical trials

Explore recruiting generalised lipodystrophy clinical trials.

Recruiting generalised lipodystrophy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Generalised Lipodystrophy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Open-label, Phase 3b study to evaluate effectiveness, safety and pharmacokinetic parameters of metreleptin in patients under 6 years of age with generalised lipodystrophy and associated diabetes mellitus and/or hypertriglyceridaemia

Italy, Germany, Belgium, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Generalised Lipodystrophy trials by city

Generalised Lipodystrophy in Toronto Generalised Lipodystrophy in Vancouver Generalised Lipodystrophy in Montreal Generalised Lipodystrophy in Calgary Generalised Lipodystrophy in Edmonton Generalised Lipodystrophy in Ottawa Generalised Lipodystrophy in Winnipeg Generalised Lipodystrophy in Quebec City Generalised Lipodystrophy in Hamilton Generalised Lipodystrophy in Kitchener Generalised Lipodystrophy in London Generalised Lipodystrophy in Halifax Generalised Lipodystrophy in New York Generalised Lipodystrophy in Los Angeles Generalised Lipodystrophy in Chicago Generalised Lipodystrophy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease